This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analysts' Actions: GSK KLAC MTB VMW APH


Amphenol (APH - Get Report) downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $65 price target.

Berkshire Hathaway (A shares) (BRK.A) downgraded to hold at TheStreet Ratings.

Berkshire Hathaway (B shares) (BRK.B) downgraded to hold at TheStreet Ratings.

Freescale Semi (FSL) rated new Neutral at UBS. $11.75 price target. Limited near term catalysts as turnaround in progress.

Globus Medical (GMED) rated new Buy at Goldman. $18 price target. Company can deliver 13% annual sales growth and is reasonably valued.

Globus Medical rated new Outperform at Oppenheimer. $18 price target. Company is growing faster than its peers and expanding internationally.

GlaxoSmithKline (GSK - Get Report) downgraded at UBS to Neutral from Buy, UBS said. $48.18 price target. Valuation, earnings visibility limit potential for further upside.

KLA-Tencor (KLAC - Get Report) downgraded at Deutsche from Hold to Sell, Deutsche Bank said. $44 price target. Company is leveraged to lower foundry spending.

Pioneer Southwest (PSE) downgraded at UBS to Sell from Neutral, UBS said. $24 price target. Limited hedge book relative to peers.


Gilead (GILD) estimates, target increased at Jefferies. GILD estimates were raised through 2013, Jefferies said. Stribild quad pill was approved with the FDA and the company announced higher pricing. Hold rating and new $55 price target.

Ingersoll-Rand (IR) target raised at UBS to $54, UBS said. Several potential catalysts including improving HVAC business conditions. Buy rating.

M&T Bank (MTB - Get Report) numbers boosted at Credit Suisse. Shares of MTB now seen reaching $102, according to Credit Suisse. Estimates also upped, as the HCBK acquisition should add to earnings. Neutral rating.

PVH (PVH) estimates, target raised at Brean. Shares of PVH now seen reaching $115, according to Brean Murray. Estimates also increased, as the company is seeing better growth across the board. Buy rating.

Rackspace (RAX) target boosted at JMP. Shares of RAX now seen reaching $65, according to JMP Securities. Company can continue to grow through its potential inclusion in the OpenStack Foundation. Outperform rating.

VMWare (VMW - Get Report) target raised at ThinkEquity to $105. Company can create a true enterprise datacenter destination. Buy rating.

>To submit a news tip, email:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
APH $58.24 1.60%
GSK $47.82 0.23%
KLAC $63.15 -1.17%
MTB $122.45 -0.23%
VMW $86.08 0.13%


DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs